Shares of Cipla slipped 5 per cent to Rs 910 on the BSE in Tuesday's intra-day trade after more than 2 per cent of the total equity of the pharmaceutical company changed hands via block deal.

At 09:15 am, around 20.7 million equity shares, representing 2.57 per cent of total equity of Cipla, changed hands on the BSE, the exchange data showed. The name of the buyers could not be ascertained immediately.

Shares of Manappuram Finance hit 52-week low of Rs 128.70 after they slipped 10 per cent on the BSE in Tuesday's intra-day trade after the financier reported 46 per cent year-on-year (YoY) drop in consolidated net profit at Rs 261 crore in December quarter (Q3FY22), due to weak operational performance. Net interest income (NII) fell 12 per cent YoY to Rs 915 crore driven by a sharp compression in spreads.

The stock of the gold finance company has fallen below its previous low of Rs 139, touched on April 22, 2021.

As the COVID-19 positivity rate and the number of daily infections declined, Andhra Pradesh government lifted the night curfew.

Chief Minister YS Jagan Mohan Reddy held a review meeting on the prevailing situation of COVID-19 on Monday, as per Chief Minister's Office.

During the review meeting, the Chief Minister said that COVID-19 precautions must be taken at all times, especially in the public and commercial spaces by wearing masks.

A high voter turnout of nearly 79 percent in Goa and moderate polling of 65.1 percent in Uttarakhand was recorded on Monday during assembly elections in the two states that passed off peacefully.

Uttar Pradesh witnessed 60.44 percent voting till 5 PM in the second phase of the state polls held amid tight security.

Oil prices surged over 2% on Monday to their highest in more than seven years as Ukraine's president declared a day of unity for Feb. 16, a date that some Western media have cited as a possible start of a Russian invasion.

Russia is one of the world's largest oil and gas producers, and fears that it could invade Ukraine have driven the rally in oil closer to $100 per barrel, a level not seen since 2014.

The global coronavirus caseload has topped 413.3 million, while the deaths have surged to more than 5.82 million and vaccinations to over 10.22 billion, according to Johns Hopkins University.

In its latest update on Tuesday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and the death toll stood at 413,307,484 and 5,825,680, respectively, while the total number of vaccine doses administered has increased to 10,222,672,400.

Mumbai-based real estate major Hiranandani Group has announced its foray into technology-led consumer services with its new venture ‘Tez Platforms’, which is set to launch this year, at an initial outlay of about Rs 1,000 crore. And, over the next 2-3 years, it plans to invest about Rs 3,500 crore in the venture.

The company will focus on large opportunities in social media, entertainment, gaming and e-sports, e-commerce, personal mobility, artificial intelligence and blockchain-linked solutions.

Oyo IPO: In a breather to IPO-bound Oyo, the Delhi High Court rejected Zostel's plea claiming 7 per cent shareholding in Oyo.

The Softbank-backed Oyo has been in a legal tussle with Zo Rooms after the latter filed a case in the Delhi HC last year to restrain Oyo from going for a listing. The root of the dispute between the two parties lies in a failed buyout deal 6 years ago, which Zostel claims was binding on Oyo.

In a significant development for the performance-linked incentive (PLI) scheme, Anil Agarwal-led Vedanta and Hon Hai Technology Group (also known as Foxconn) have formed a joint venture (JV) to manufacture semiconductors in India. This is the first JV in the electronics manufacturing space after the PLI policy, a joint statement issued by the companies said.

In December 2021, the Centre had cleared a PLI scheme for semiconductor and display board production in the country targeting an investment of Rs 76,000 crore over the next five to six years.

Biological E has sought emergency use authorisation from India's drug regulator for its COVID-19 vaccine Corbevax for the 12 to 18 years age group, official sources said on Sunday.

The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, for restricted use in emergency situation among adults on December 28.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.